The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women | BMC Women’s Health

  • 1.

    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article 

    Google Scholar
     

  • 2.

    Pace LE, Shulman LN. Breast cancer in sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    Rambau P, Masalu N, Jackson K, Chalya P, Serra P, Bravaccini S. Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients. BMC Res Notes. 2014;7(1):1–6.


    Google Scholar
     

  • 4.

    Mansouri H, Mnango LF, Magorosa EP, Sauli E, Mpolya EA. Ki-67, p53 and BCL-2 expressions and their association with clinical histopathology of breast cancer among women in Tanzania. Sci Rep. 2019;9(1):1–11.


    Google Scholar
     

  • 5.

    Komen SG. Tanzania Breast Health Care Assessment: an assessment of breast cancer early detection, diagnosis and treatment in Tanzania. A report carried out on behalf of the Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania.2017.

  • 6.

    Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol J Pathol Soc Gr Brit Ire. 2005;205(2):248–54.

    CAS 

    Google Scholar
     

  • 7.

    Algazzar MAA, Elsayed EE-M, Alhanafy AM, Mousa WA. Breast cancer imaging features as a predictor of the hormonal receptor status, HER2neu expression and molecular subtype. Egypt J Radiol Nucl Med. 2020;51(1):1–10.


    Google Scholar
     

  • 8.

    Cho N. Molecular subtypes and imaging phenotypes of breast cancer. Ultrasonog. 2016;35(4):281.


    Google Scholar
     

  • 9.

    Rakha EA, Green AR. Molecular classification of breast cancer: what the pathologist needs to know. Pathology. 2017;49(2):111–9.

    CAS 
    PubMed 

    Google Scholar
     

  • 10.

    Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, et al. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Womens Health. 2018;18(1):1–8.


    Google Scholar
     

  • 11.

    Seshie B, Adu-Aryee NA, Dedey F, Calys-Tagoe B, Clegg-Lamptey J-N. A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana. BMC Clin Pathol. 2015;15(1):14.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 12.

    Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. As Pac J Public Health. 2013;25(5):368–87.


    Google Scholar
     

  • 13.

    Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144(1):1–10.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 14.

    Wang JM, Wang J, Zhao HG, Liu TT, Wang FY. Reproductive risk factors associated with breast cancer molecular subtypes among young women in Northern China. BioMed Res Int. 2020;2020:1–9.


    Google Scholar
     

  • 15.

    Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol. 2002;156(6):507–16.

    PubMed 

    Google Scholar
     

  • 16.

    Huang W-Y, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151(7):703–14.

    CAS 
    PubMed 

    Google Scholar
     

  • 17.

    Williams LA, Casbas-Hernandez P, Nichols HB, Tse CK, Allott EH, Carey LA, et al. Risk factors for luminal a ductal carcinoma in situ (DCIS) and invasive breast cancer in the carolina breast cancer study. PLoS ONE. 2019;14(1):e0211488.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 18.

    Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, et al. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Res. 2017;19(1):1–12.


    Google Scholar
     

  • 19.

    Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen AH. Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the nurses’ health studies. Int J cancer. 2016;138(10):2346–56.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 20.

    Lakhani SR, Ellis IO, Schnitt S, Tan PH, van de Vijver M. WHO classification of tumours of the breast. 2012.

  • 21.

    Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10.

    CAS 
    PubMed 

    Google Scholar
     

  • 22.

    Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arc Pathol Lab Med. 2010;134(7):e48–72.

    CAS 

    Google Scholar
     

  • 23.

    Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz A, Greene F. AJCC cancer staging manual. New York: Springer; 2010.


    Google Scholar
     

  • 24.

    Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, et al. Urban–rural differences in breast cancer incidence in Egypt (1999–2006). Breast. 2010;19(5):417–23.

    PubMed 

    Google Scholar
     

  • 25.

    Errahhali ME, Errahhali ME, Ouarzane M, El Harroudi T, Afqir S, Bellaoui M. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases. BMC Womens Health. 2017;17(1):3.


    Google Scholar
     

  • 26.

    Alnegheimish NA, Alshatwi RA, Alhefdhi RM, Arafah MM, AlRikabi AC, Husain S. Molecular subtypes of breast carcinoma in Saudi Arabia: a retrospective study. Saudi Med J. 2016;37(5):506.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 27.

    Redondo CM, Gago-Domínguez M, Ponte SM, Castelo ME, Jiang X, García AA, et al. Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS ONE. 2012;7(7):e40543.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 28.

    Mwakigonja AR, Lushina NE, Mwanga A. Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania. Infect Agents Cancer. 2017;12(1):60.


    Google Scholar
     

  • 29.

    Sawe RT, Mining SK, Ofulla AV, Patel K, Guyah B, Chumba D, et al. Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya. Trop Med Health. 2017;45(1):19.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 30.

    Brewster AM, Chavez-MacGregor M, Brown P. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lanc Oncol. 2014;15(13):e625–34.


    Google Scholar
     

  • 31.

    Effi AB, Koui BS, Koffi KD, Traore ZC, Kouyate M. Breast cancer molecular subtypes defined by ER/PR and HER2 status: association with clinicopathologic parameters in Ivorian patients. As Pac J Cancer Prev. 2016;17(4):1973–8.


    Google Scholar
     

  • 32.

    Nafissi N, Faraji M, Hosseini M, Shojaee L, Ziaei F, Akbari ME, et al. Relationships between reproductive risk factors for breast cancer and tumor molecular subtypes. As Pac J Cancer Prev. 2018;19(7):1767.

    CAS 

    Google Scholar
     

  • 33.

    Al-Thoubaity FK. Molecular classification of breast cancer: a retrospective cohort study. Ann Med Surg. 2020;49:44–8.


    Google Scholar
     

  • 34.

    Belhadj A, Addou-Klouche L, Benyelles MK, Bendaoud A, Ziane I, Zakmout B, et al. Epidemiological study and molecular breast cancer subtypes distribution among West Algerian patients. J Int Res Med Pharm Sci. 2016;6:18–24.


    Google Scholar
     

  • 35.

    Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast. 2013;22(3):344–50.

    PubMed 

    Google Scholar
     

  • 36.

    Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016;49:65–76.

    PubMed 

    Google Scholar
     

  • 37.

    Dall GV, Britt KL. Estrogen effects on the mammary gland in early and late life and breast cancer risk. Front Oncol. 2017;7:110.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 38.

    Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami H-O. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994;331(1):5–9.

    CAS 
    PubMed 

    Google Scholar
     

  • 39.

    Romieu I, Biessy C, Carayol M, His M, Torres-Mejía G, Ángeles-Llerenas A, et al. Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. Sci Rep. 2018;8(1):1–10.

    CAS 

    Google Scholar
     

  • 40.

    Dianatinasab M, Fararouei M, Daneshi N, Rezaian S, Mohammadianpanah M, Chaman R, et al. Heterogeneity in risk factors for ductal and lobular breast carcinomas: a case–control study. Int J Cancer. 2019;145(11):2917–25.

    CAS 
    PubMed 

    Google Scholar
     

  • 41.

    Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benítez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010;12(6):1–11.


    Google Scholar
     

  • 42.

    Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, et al. Assessment of breast cancer risk factors reveals subtype heterogeneity. Cancer Res. 2017;77(13):3708–17.

    CAS 
    PubMed 

    Google Scholar
     

  • 43.

    Sayed S, Fan S, Moloo Z, Wasike R, Bird P, Saleh M, et al. Breast Cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya. 2021.

  • 44.

    Victora CG, Bahl R, Barros AJ, França GV, Horton S, Krasevec J, et al. Breast-feeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 45.

    Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. JNCI Monogr. 2000;2000(27):17–37.


    Google Scholar
     

  • 46.

    John EM, Hines LM, Phipps AI, Koo J, Longacre TA, Ingles SA, et al. Reproductive history, breast-feeding and risk of triple negative breast cancer: the breast cancer etiology in minorities (BEM) study. Int J Cancer. 2018;142(11):2273–85.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 47.

    Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, et al. Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Res Treat. 2019;174(2):453–61.

    CAS 
    PubMed 

    Google Scholar
     

  • 48.

    Devi CB, Tang TS, Corbex M. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak. Malaysia Int J cancer. 2012;131(12):2869–77.

    CAS 
    PubMed 

    Google Scholar
     

  • 49.

    Fourati A, Boussen H, El May MV, Goucha A, Dabbabi B, Gamoudi A, et al. Descriptive analysis of molecular subtypes in Tunisian breast cancer. Asia Pac J Clin Oncol. 2014;10(2):e69–74.

    PubMed 

    Google Scholar
     

  • 50.

    Elgasim MAEA, Abusin HM, Nouri MM. Breast cancer molecular subtypes in relation to age, stage and grade among Sudanese women patients in Khartoum oncology hospital (2013–2017). Int Res J Oncol. 2019;2:1–9.


    Google Scholar
     

  • 51.

    Sengal AT, Haj-Mukhtar NS, Elhaj AM, Bedri S, Kantelhardt EJ, Mohamedani AA. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series. BMC Cancer. 2017;17(1):804.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 52.

    Chukwuma UJ, Arinze NM, Thaddeus ON, Kenneth EC, Felix EO, Chudi OO, et al. The histological subtypes of breast cancer seen in a tertiary hospital in South-East, Nigeria. Glob J Health Sci. 2020;12(6):93.


    Google Scholar
     

  • 53.

    Iliyasu Y, Atanda AT. Molecular subtyping of carcinoma of the female breast in a tertiary teaching hospital in Northern Nigeria. Ann Trop Pathol. 2019;10(1):20.


    Google Scholar
     

  • 54.

    Omoruyi KA, Nnoli MA, Ebughe GA, Irabor GI, Isiwele EM. Prevalence of molecular subtypes of breast carcinoma in University of Calabar Teaching Hospital using immunohistochemistry as surrogates for intrinsic DNA gene characteristics. 2018.

  • 55.

    Aman NA, Doukoure B, Koffi KD, Koui BS, Traore ZC, Kouyate M, et al. HER2 overexpression and correlation with other significant clinicopathologic parameters in Ivorian breast cancer women. BMC Clin Pathol. 2019;19(1):1–6.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 56.

    Traoré B, Koulibaly M, Diallo A, Bah M. Molecular profile of breast cancers in Guinean oncological settings. Pan Afr Med J. 2019. https://doi.org/10.11604/pamj.2019.33.22.18189.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 57.

    Ly M, Antoine M, Dembélé AK, Levy P, Rodenas A, Touré BA, et al. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Oncology. 2012;83(5):257–63.

    PubMed 

    Google Scholar
     

  • 58.

    Mvila GL, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens M-R, et al. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium. Breast. 2015;24(5):642–8.


    Google Scholar
     

  • 59.

    Miguel F, Lopes LV, Ferreira E, Ribas E, Pelaez AF, Leal C, et al. Breast cancer in Angola, molecular subtypes: a first glance. Ecancer Med Sci. 2017. https://doi.org/10.3332/ecancer.2017.763.

    Article 

    Google Scholar
     

  • 60.

    McCormack VA, Joffe M, van den Berg E, Broeze N, dos Santos SI, Romieu I, et al. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res. 2013;15(5):R84.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 61.

    Bhatia RK, Narasimhamurthy M, Martei YM, Prabhakar P, Hutson J, Chiyapo S, et al. Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana. Infect Agents Cancer. 2019;14(1):28.


    Google Scholar
     

  • 62.

    Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. Pan Afr Med J. 2014. https://doi.org/10.11604/pamj.2014.17.249.3305.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-021-01536-6

    Share